Search - tctmd.com

Displaying 61 - 80 of 538

Sort: Relevancy | Date

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

News Conference News AHA 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

November 10, 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

News Conference News AHA 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

November 10, 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

Lower Hypertension Range Tied to Heightened CVD Risk in Younger Adults

News Daily News

Lower Hypertension Range Tied to Heightened CVD Risk in Younger Adults

November 08, 2018

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

News Daily News

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Michael O'Riordan

November 06, 2018

INR Test Strips Recalled Due to Inaccurate Measurements

News Daily News

INR Test Strips Recalled Due to Inaccurate Measurements

November 02, 2018

Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes

News Daily News

Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes

Michael O'Riordan

November 02, 2018

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

News Daily News

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

November 01, 2018

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

FDA: Contaminated Irbesartan Now Under Voluntary Recall

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

TCTMD’s Top 10 Most Popular Stories for October 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

October 31, 2018

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

News Daily News

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

October 30, 2018

Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality

News Daily News

Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality

Michael O'Riordan

October 30, 2018

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

News Daily News

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Yael L. Maxwell

October 30, 2018

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

Office and Home BPs Seem to Be In Sync at Lower Levels, Study Suggests

News Daily News

Office and Home BPs Seem to Be In Sync at Lower Levels, Study Suggests

October 29, 2018

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

News Daily News

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

October 29, 2018

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

News Daily News

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

October 26, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.